| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Feb―21 |
Long COVID has variable incidence and clinical presentations: our 6-country collaborative study |
Sandor Szabo, Iryna Muzyka, Veronika Muller, Attila J. Szabo, Attila Szijártó, Klara Gyires, et al. (+10) Tamas Doczi, Jozsef Janszky, Andreas Stengel, Siri Göpel, Antonia Trichopoulou, Rafael Diaz, Nicte Camacho, George Malatinszky, Nils Lambrecht, Oksana Zayachkivska |
| 2 |
[GO] |
2024―Dec―23 |
Across-the-board review on Omicron SARS-CoV-2 variant |
Rufaida Wasim, Asad Ahmad |
| 3 |
[GO] |
2024―Nov―27 |
Evaluating diclofenac’s risks in COVID-19: strategies for mitigating adverse outcomes |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam |
| 4 |
[GO] |
2024―Nov―13 |
Role of intravenous vitamin C on outcomes in hospitalized patients with moderate or severe COVID-19: a real life data of Turkish patients |
Burak Uz, Özgür İnce, Can Gümüş, Feyzi Gökosmanoğlu, Emrah Gökay Özgür, Gülnaz Nural Bekiroğlu |
| 5 |
[GO] |
2024―Oct―16 |
Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants |
Hussein Sabit, Shaimaa Abdel-Ghany, Mahmoud S. Abdallah, Osama Abul-Maaty, Ahmed I. Khoder, Nabil A. Shoman, et al. (+4) Mohamed Sameh Farrag, Pavel Martasek, Ayman M. Noreddin, Mahmoud Nazih |
| 6 |
[GO] |
2024―Oct―03 |
Glucocorticoid treatment during COVID-19 infection: does it affect the incidence of long COVID? |
Polina Specktor, Dana Hadar, Hilla Cohen |
| 7 |
[GO] |
2024―Sep―23 |
The role of traditional NSAIDs and selective COX-2 inhibitors on COVID-19 outcomes: a real-world data study |
Narmeen Mallah, Irene Visos-Varela, Bahi Takkouche, Rosendo Bugarín-González, María Piñeiro-Lamas, Teresa Herdeiro, et al. (+16) Maruxa Zapata-Cachafeiro, Almudena Rodríguez-Fernández, Angel Salgado-Barreira, Adolfo Figueiras, Eduardo Carracedo-Martínez, Rosa M. García-Álvarez, Francisco J. González-Barcala, Teresa M Herdeiro, Martina Lema-Oreiro, Samuel Pintos-Rodríguez, Maria Piñeiro-Lamas, Manuel Portela-Romero, Angela Prieto-Campo, Almudena Rodriguez-Fernández, Marc Saez, Margarita Taracido-Trunk |
| 8 |
[GO] |
2024―Sep―03 |
The impact of vitamin D administration on mortality in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Zhiyun Wong, Kaeshaelya Thiruchelvam |
| 9 |
[GO] |
2024―Aug―10 |
Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management |
Samar A. Antar, Nada A. Ashour, Amir O. Hamouda, Ayman M. Noreddin, Ahmed A. Al-Karmalawy |
| 10 |
[GO] |
2024―Aug―09 |
Impact of corticosteroid doses on prognosis of severe and critical COVID-19 patients with Omicron variant infection: a propensity score matching study |
Shiyao Wang, Ziying Chen, Xinran Zhang, Xiaojing Wu, Yuqiong Wang, Qi Zhang, et al. (+8) Linna Huang, Xiaoyang Cui, Ying Cai, Xu Huang, Jingen Xia, Sichao Gu, Min Li, Qingyuan Zhan |
| 11 |
[GO] |
2024―Jul―24 |
Taming the storm: potential anti-inflammatory compounds targeting SARS-CoV-2 MPro |
Débora Bublitz Anton, Jeferson Camargo de Lima, Bruno Rampanelli Dahmer, Ana Micaela Camini, Marcia Inês Goettert, Luis Fernando Saraiva Macedo Timmers |
| 12 |
[GO] |
2024―May―21 |
Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols |
Abdul Mannan Baig, Sandy Rosko, Beate Jaeger, Joachim Gerlach, Hans Rausch |
| 13 |
[GO] |
2024―May―19 |
Surveying haemoperfusion impact on COVID-19 from machine learning using Shapley values |
Behzad Einollahi, Mohammad Javanbakht, Mehrdad Ebrahimi, Mohammad Ahmadi, Morteza Izadi, Sholeh Ghasemi, et al. (+4) Zahra Einollahi, Bentolhoda Beyram, Abolfazl Mirani, Ehsan Kianfar |
| 14 |
[GO] |
2024―May―02 |
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study |
Almudena Rodríguez-Fernández, Irene Visos-Varela, Maruxa Zapata-Cachafeiro, Samuel Pintos-Rodríguez, Rosa M. García-Álvarez, Teresa M. Herdeiro, et al. (+17) María Piñeiro-Lamas, Adolfo Figueiras, Ángel Salgado-Barreira, Rosendo Bugarín-González, Eduardo Carracedo-Martínez, Rosa M García-Álvarez, Francisco J González-Barcala, Teresa M Herdeiro, Martina Lema-Oreiro, Narmeen Mallah, Maria Piñeiro-Lamas, Manuel Portela-Romero, Angela Prieto-Campo, Almudena Rodriguez-Fernández, Marc Saez, Angel Salgado-Barreira, Margarita Taracido-Trunk |
| 15 |
[GO] |
2024―Apr―15 |
Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient |
Rosa María García-Álvarez, Maruxa Zapata-Cachafeiro, Irene Visos-Varela, Almudena Rodríguez-Fernández, Samuel Pintos-Rodríguez, Maria Piñeiro-Lamas, et al. (+12) Teresa M. Herdeiro, Adolfo Figueiras, Angel Salgado-Barreira, Rosendo Bugarín-González, Eduardo Carracedo-Martínez, Francisco J. González-Barcala, Martina Lema-Oreiro, Narmeen Mallah, Manuel Portela-Romero, Angela Prieto-Campo, Marc Saez, Margarita Taracido-Trunk |
| 16 |
[GO] |
2024―Mar―16 |
Evaluation of the relationship of treatment and vaccination with prognosis in patients with a diagnosis of COVID-19 |
Seyma Oncu, Derya Korkmaz |
| 17 |
[GO] |
2024―Jan―31 |
Repurposing metformin to manage idiopathic or long COVID Tinnitus: self-report adopting a pathophysiological and pharmacological approach |
Mina T. Kelleni |
| 18 |
[GO] |
2023―Dec―20 |
Mesenchymal stem cell therapy for COVID-19 infection |
Seyyed Mohammad Matin Alavi-Dana, Yazdan Gholami, Mohammadreza Meghdadi, Mohammad Saleh Fadaei, Vahid Reza Askari |
| 19 |
[GO] |
2023―Dec―14 |
Intravenous immunoglobulin for treatment of hospitalized COVID-19 patients: an evidence mapping and meta-analysis |
Mei-xuan Li, Yan-fei Li, Xin Xing, Jun-qiang Niu, Liang Yao, Meng-ying Lu, et al. (+15) Ke Guo, Mi-na Ma, Xiao-tian Wu, Ning Ma, Dan Li, Zi-jun Li, Ling Guan, Xiao-man Wang, Bei Pan, Wen-ru Shang, Jing Ji, Zhong-yang Song, Zhi-ming Zhang, Yong-feng Wang, Ke-hu Yang |
| 20 |
[GO] |
2023―Nov―27 |
Therapeutic potential and possible mechanisms of ginseng for depression associated with COVID-19 |
Fangyi Zhao, Kai Zhang, Hongyu Chen, Tianqi Zhang, Jiayu Zhao, Qianyu Lv, et al. (+4) Qin Yu, Mengyu Ruan, Ranji Cui, Bingjin Li |
| 21 |
[GO] |
2023―Nov―13 |
Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy |
Adel A. Gomaa, Yasmin A. Abdel-Wadood, Romany H. Thabet, Ghada A. Gomaa |
| 22 |
[GO] |
2023―Oct―17 |
Efficacy and safety of licorice (Glycyrrhiza glabra) in moderately ill patients with COVID-19: a randomized controlled trial |
Ali Ameri, Mehdi Farashahinejad, Parivash Davoodian, Omid Safa, Amin Kusha, Habib Dadvand, et al. (+2) Soheil Hassanipour, Mohammad Fathalipour |
| 23 |
[GO] |
2023―Oct―17 |
The effect of probiotics on the risk of mortality in patients with COVID-19: systematic review and meta-analysis of randomized trials |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 24 |
[GO] |
2023―Oct―16 |
The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regression |
Arto Yuwono Soeroto, Hendarsyah Suryadinata, Theo Audi Yanto, Timotius Ivan Hariyanto |
| 25 |
[GO] |
2023―Oct―13 |
Cytokine profiles in COVID-19 patients undergoing adjunct ozone therapy: some comments |
Salvatore Chirumbolo, Sergio Pandolfi, Marianno Franzini, Luigi Valdenassi |
| 26 |
[GO] |
2023―Oct―09 |
Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies |
Zahra Shafaghat, Amir-Hossein Khosrozadeh Ghomi, Hossein Khorramdelazad, Elaheh Safari |
| 27 |
[GO] |
2023―Oct―07 |
Systematic review and meta-analysis of anti-CD20 treatments in patients with COVID-19: an assessment of severe illness and mortality outcomes |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam |
| 28 |
[GO] |
2023―Sep―29 |
Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markers |
Pavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi |
| 29 |
[GO] |
2023―Aug―21 |
Ibuprofen, other NSAIDs and COVID-19: a narrative review |
William Laughey, Imran Lodhi, Graham Pennick, Lucinda Smart, Olutoba Sanni, Suneet Sandhu, Bruce Charlesworth |
| 30 |
[GO] |
2023―Aug―07 |
Combined systemic inflammatory indexes as reflectors of outcome in patients with COVID-19 infection admitted to ICU |
Amir Tahavvori, Reza Mosaddeghi-Heris, Faezeh Ghanbari Sevari, Seyed Mohammad Amin Alavi, Peghah Panahi, Niloufar Abbasi, et al. (+2) Hamed Rahmani Youshanlouei, Seyyed Sina Hejazian |
| 31 |
[GO] |
2023―Jul―17 |
Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID |
Tamás Constantin, Tamás Pék, Zsuzsanna Horváth, Diána Garan, Attila J. Szabó |
| 32 |
[GO] |
2023―Jul―15 |
Effect of treatment regimen of the rheumatoid arthritis patients on the risk of coronavirus disease 2019 by modulating the inflammatory mediators |
Zahra Bagheri-Hosseinabadi, Alireza Dehghani, Mohammad Amin Lotfi, Mitra Abbasifard |
| 33 |
[GO] |
2023―Jul―12 |
Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement |
Hadi Esmaeili Gouvarchin Ghaleh, Morteza Izadi, Mohammad Javanbakht, Mostafa Ghanei, Behzad Einollahi, Nematollah Jonaidi Jafari, et al. (+11) Gholamhossein Alishiri, Jafar Aslani, Hassan Abolghasemi, Vincenzo Simonetti, Mostafa Khafaei, Shi Zhao, Seyed Hassan Saadat, Majid Ahmadi, Shahram Parvin, Soheil Vazifedoust, Akbar Ghorbani Alvanagh |
| 34 |
[GO] |
2023―Jun―21 |
Long COVID and possible preventive options |
Szilvia Sebők, Klara Gyires |
| 35 |
[GO] |
2023―Jun―16 |
The African Kelleni’s roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one |
Mina T. Kelleni |
| 36 |
[GO] |
2023―Jun―02 |
Intermediate- to high-dose dexamethasone versus low-dose dexamethasone in patients with COVID-19 requiring respiratory support: a systematic review and meta-analysis of randomized trials |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 37 |
[GO] |
2023―Jun―01 |
Nutritional deficiencies and long COVID: correspondence |
Amnuay Kleebayoon, Viroj Wiwanitkit |
| 38 |
[GO] |
2023―May―19 |
Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach |
Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Nada A. Ashour, Walaa A. Negm |
| 39 |
[GO] |
2023―May―15 |
The post-COVID stress syndrome: from the three-stage stress response of Hans Selye to COVID-19 |
Sandor Szabo |
| 40 |
[GO] |
2023―Apr―20 |
Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients’ susceptibility to COVID-19 to the possible caution of future global diabetes tsunami |
Yasamin Sharbatdar, Ronak Mousavian, Seyed Mostafa Noorbakhsh Varnosfaderani, Fatemeh Aziziyan, Mahsa Liaghat, Payam Baziyar, et al. (+6) Ali Yousefi Rad, Chanour Tavakol, Amir Mansour Moeini, Mohsen Nabi-Afjadi, Hamidreza Zalpoor, Fatemeh Kazemi-Lomedasht |
| 41 |
[GO] |
2023―Apr―18 |
The effect of vitamin C on the risk of mortality in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials |
Chia Siang Kow, Syed Shahzad Hasan, Dinesh Sangarran Ramachandram |
| 42 |
[GO] |
2023―Apr―10 |
Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19 |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 43 |
[GO] |
2023―Apr―05 |
Fatigue, sleepiness and sleep quality are SARS-CoV-2 variant independent in patients with long COVID symptoms |
Anna Reka Percze, Alexandra Nagy, Lorinc Polivka, Eniko Barczi, Ibolya Czaller, Zsuzsanna Kovats, et al. (+4) Janos Tamas Varga, Judit H. Ballai, Veronika Muller, Gabor Horvath |
| 44 |
[GO] |
2023―Mar―26 |
Real-world practice of the Egyptian Kelleni’s protocol amid changing tropism of SARS-CoV-2 omicron BA.5.2.1.7, XBB 1.5 and CH.1.1 subvariants: a multi-purpose protocol |
Mina T. Kelleni |
| 45 |
[GO] |
2023―Mar―25 |
What is the role of brown adipose tissue in metabolic health: lessons learned and future perspectives in the long COVID? |
Iryna Muzyka, Oleh Revenko, Iryna Kovalchuk, Maryanna Savytska, Anna Bekesevych, Roksolana Kasko, Oksana Zayachkivska |
| 46 |
[GO] |
2023―Mar―24 |
Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease |
Dorottya Fesu, Lorinc Polivka, Eniko Barczi, Marcell Foldesi, Gabor Horvath, Edit Hidvegi, et al. (+2) Aniko Bohacs, Veronika Muller |
| 47 |
[GO] |
2023―Mar―22 |
Long COVID prevalence and physiology-centered risks: population-based study in Ukraine |
Iryna Muzyka, Mariana Yakhnytska, Maryana Savytska, Oksana Zayachkivska |
| 48 |
[GO] |
2023―Mar―21 |
What is the role of brown adipose tissue in metabolic health: lessons learned and future perspectives in the long COVID? |
Iryna Muzyka, Oleh Revenko, Iryna Kovalchuk, Maryanna Savytska, Anna Bekesevych, Oksana Zayachkivska |
| 49 |
[GO] |
2023―Mar―15 |
Nutritional deficiencies that may predispose to long COVID |
John V. Schloss |
| 50 |
[GO] |
2023―Mar―09 |
COVID-19-induced neurological symptoms: focus on the role of metal ions |
Yi-Yue Zhang, Kai-Di Ren, Xiu-Ju Luo, Jun Peng |
| 51 |
[GO] |
2023―Feb―27 |
Could the fibromyalgia syndrome be triggered or enhanced by COVID-19? |
Maria Fernanda Pessano Fialho, Evelyne Silva Brum, Sara Marchesan Oliveira |
| 52 |
[GO] |
2023―Feb―01 |
The direct correlation between microbiota and SARS-CoV-2 infectious disease |
Antonio Vitiello, Francesco Ferrara, Andrea Zovi |
| 53 |
[GO] |
2023―Jan―27 |
High-dose intravenous anakinra treatment is safe and effective in severe and critical COVID-19 patients: a propensity score-matched study in a single center |
Murat Bektaş, Servet Yüce, Mustafa Ay, Muhammed Hamdi Uyar, Mustafa Erkut Önder, Muhammed İkbal Kılıç |
| 54 |
[GO] |
2023―Jan―07 |
A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective? |
Mohsen Nabi-Afjadi, Fatemeh Mohebi, Hamidreza Zalpoor, Fatemeh Aziziyan, Abdullatif Akbari, Hemen Moradi-Sardareh, et al. (+3) Elham Bahreini, Amir Mansour Moeini, Hossein Effatpanah |
| 55 |
[GO] |
2023―Jan―04 |
Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic potential of mesenchymal stem cells |
Babak Arjmand, Sepideh Alavi-Moghadam, Masoumeh Sarvari, Mostafa Rezaei-Tavirani, Ahmad Rezazadeh- Mafi, Rasta Arjmand, et al. (+3) Mohsen Nikandish, Ensieh Nasli-Esfahani, Bagher Larijani |
| 56 |
[GO] |
2022―Dec―20 |
The effect of ramatroban on cytokine and thrombotic storms in Covid-19 |
Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Hebatallah M. Saad, Gaber El-Saber Batiha |
| 57 |
[GO] |
2022―Dec―09 |
A perspective study of the possible impact of obeticholic acid against SARS-CoV-2 infection |
Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Fadia S. Youssef, Suzy A. El-Sherbeni, Walaa A. Negm |
| 58 |
[GO] |
2022―Nov―29 |
Efficacy and safety of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysis |
An-ran Xi, Yi-jun Luo, Jin-Tao Guan, Wei-Jie Wang, Zheng-Hao Xu |
| 59 |
[GO] |
2022―Nov―24 |
Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal |
Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Mubarak Alruwaili, Raed AlRuwaili, Sarah M. Albogami, et al. (+3) Mohammed Alorabi, Hebatallah M. Saad, Jesus Simal-Gandara |
| 60 |
[GO] |
2022―Nov―19 |
Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial |
Ali Ameri, Masoomeh Frouz Asadi, Ava Ziaei, Majid Vatankhah, Omid Safa, Manoochehr Kamali, et al. (+3) Mohammad Fathalipour, Masoumeh Mahmoodi, Soheil Hassanipour |
| 61 |
[GO] |
2022―Oct―25 |
Immunogenicity and safety of the CoronaVac and BNT162b2 Covid-19 vaccine in patients with inflammatory rheumatic diseases and healthy adults: comparison of different vaccines |
Sevilay Batıbay, Rezan Koçak Ulucaköy, Zafer Günendi, Işıl Fidan, Gülendam Bozdayı, Feride Nur Göğüş |
| 62 |
[GO] |
2022―Oct―02 |
The role of berberine in Covid-19: potential adjunct therapy |
Ahmad O. Babalghith, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Michel De Waard, Sadiq Mohammed Al-Hamash, Sabatier Jean-Marc, et al. (+2) Walaa A. Negm, Gaber El-Saber Batiha |
| 63 |
[GO] |
2022―Sep―30 |
Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy? |
Basil Mohammed Alomair, Hayder M. Al-kuraishy, Ali K. Al-Buhadily, Ali I. Al-Gareeb, Michel De Waard, Engy Elekhnawy, Gaber El-Saber Batiha |
| 64 |
[GO] |
2022―Sep―22 |
Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild-moderate COVID-19 and prevention of post-COVID cognitive impairment |
Adel A. Gomaa, Yasmin A. Abdel-Wadood, Mohamed A. Gomaa |
| 65 |
[GO] |
2022―Sep―16 |
Potential role of lipoxin in the management of COVID-19: a narrative review |
Gaber El-Saber Batiha, Ali I. Al-Gareeb, Engy Elekhnawy, Hayder M. Al-kuraishy |
| 66 |
[GO] |
2022―Sep―12 |
Association between chemosensory dysfunctions and inflammatory biomarkers in patients with SARS-CoV-2 infection: a systematic review and meta-analysis |
Elisama Gomes Magalhães de Melo, Rayle Monteiro Andrade, Sara Juliana de Abreu de Vasconcellos, Priscila Lima dos Santos, Diego Moura Tanajura, Lucindo José Quintans-Júnior, et al. (+2) Jullyana de Souza Siqueira Quintans, Paulo Ricardo Martins-Filho |
| 67 |
[GO] |
2022―Sep―01 |
Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID- 19) |
Banlambhabok Khongthaw, Kanika Dulta, Pankaj Kumar Chauhan, Vinod Kumar, Joshua O. Ighalo |
| 68 |
[GO] |
2022―Aug―26 |
Dysregulation of immunity in COVID-19 and SLE |
Seyyed Sina Hejazian, Seyyedeh Mina Hejazian, Farahnoosh Farnood, Sima Abedi Azar |
| 69 |
[GO] |
2022―Aug―26 |
Assessment of drugs administered in the Middle East as part of the COVID-19 management protocols |
Engy Elekhnawy, Walaa A. Negm, Suzy A. El-Sherbeni, Ahmed Zayed |
| 70 |
[GO] |
2022―Aug―22 |
Hesperetin as an anti-SARS-CoV-2 agent can inhibit COVID-19-associated cancer progression by suppressing intracellular signaling pathways |
Hamidreza Zalpoor, Maryam Bakhtiyari, Hooriyeh Shapourian, Puria Rostampour, Chanour Tavakol, Mohsen Nabi-Afjadi |
| 71 |
[GO] |
2022―Aug―18 |
Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of view |
Francesco Ferrara, Andrea Zovi, Ugo Trama, Antonio Vitiello |
| 72 |
[GO] |
2022―Aug―10 |
Pathogenic role of cytokines in COVID-19, its association with contributing co-morbidities and possible therapeutic regimens |
Ayesha Tanveer, Bushra Akhtar, Ali Sharif, Uzma Saleem, Azhar Rasul, Aftab Ahmad, Kashif Jilani |
| 73 |
[GO] |
2022―Aug―03 |
Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Walaa A. Negm, Athanasios Alexiou, Gaber El-Saber Batiha |
| 74 |
[GO] |
2022―Jul―27 |
Effects of Boswellia species on viral infections with particular attention to SARS-CoV-2 |
Zahra Jamshidi, Maryam Hashemi, Rezvan Yazdian-Robati, Leila Etemad, Zahra Salmasi, Prashant Kesharwani |
| 75 |
[GO] |
2022―Jul―14 |
Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients |
Habib Ghaznavi, Zahra Mohammadghasemipour, Milad Shirvaliloo, Mohammad Kazem Momeni, Malihe Metanat, Farzaneh Gorgani, et al. (+8) Fatemeh Abedipour, Mahdi Mohammadi, Majid Sartipi, Ali Reza Salimi Khorashad, Omolbanin Shahraki, Mohadese Ataee, Roghayeh Sheervalilou, Saman Sargazi |
| 76 |
[GO] |
2022―Jun―20 |
Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trial |
Mohammadreza Moslemi, Seyyedeh Mina Hejazian, Molod Shaddelan, Fatemeh Javanali, Alireza Mirghaffari, Armin Sadeghi, et al. (+5) Hamed Valizadeh, Akbar Sharifi, Morteza Haramshahi, Mohammadreza Ardalan, Sepideh Zununi Vahed |
| 77 |
[GO] |
2022―Jun―14 |
The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review |
Mohammed Ahmed Akkaif, Abubakar Sha’aban, Arturo Cesaro, Ammar Ali Saleh Jaber, Andrea Vergara, Ismaeel Yunusa, et al. (+6) Abubakar Ibrahim Jatau, Mustapha Mohammed, G. Saravana Govindasamy, Majed Ahmed Al-Mansoub, Muhamad Ali Sheikh Abdul Kader, Baharudin Ibrahim |
| 78 |
[GO] |
2022―May―30 |
The key role of Calpain in COVID-19 as a therapeutic strategy |
Aref Doozandeh Juibari, Mohammad Hossein Rezadoost, Masoud Soleimani |
| 79 |
[GO] |
2022―May―30 |
Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications |
Ankita Sood, Onkar Bedi |
| 80 |
[GO] |
2022―May―13 |
COVID-19 and corticosteroids: a narrative review |
Gaber El-Saber Batiha, Ali I. Al-Gareeb, Hebatallah M. Saad, Hayder M. Al-kuraishy |
| 81 |
[GO] |
2022―May―04 |
COVID-19 and the role of cytokines in this disease |
Amin Hasanvand |
| 82 |
[GO] |
2022―Apr―29 |
A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19 |
Gomaa Mostafa-Hedeab, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Philippe Jeandet, Hebatallah M. Saad, Gaber El-Saber Batiha |
| 83 |
[GO] |
2022―Apr―26 |
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Luay Alkazmi, Ola A. Habotta, Gaber El-Saber Batiha |
| 84 |
[GO] |
2022―Apr―07 |
Potential plants for inflammatory dysfunction in the SARS-CoV-2 infection |
Diorge Jônatas Marmitt |
| 85 |
[GO] |
2022―Mar―28 |
Role of triggering receptor expressed on myeloid cells-1 (TREM-1) in COVID-19 and other viral pneumonias: a systematic review and meta-analysis of clinical studies |
Yrna Lorena Matos de Oliveira, Ayane de Sá Resende, Paulo Ricardo Martins-Filho, Tatiana Rodrigues de Moura |
| 86 |
[GO] |
2022―Mar―23 |
Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR |
Nourin Shakeeb, Prashanth Varkey, Aimy Hynse, Ajit Mandlecha |
| 87 |
[GO] |
2022―Mar―22 |
Comment on “Inflawell, neutrophil-to-lymphocyte ratio and COVID-19” |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 88 |
[GO] |
2022―Mar―01 |
Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial |
Adel A. Gomaa, Hamdy S. Mohamed, Rasha B. Abd-ellatief, Mohamed A. Gomaa, Doaa S. Hammam |
| 89 |
[GO] |
2022―Feb―24 |
Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial |
Sepideh Barzin Tond, Laurent Balenci, Nasim Khajavirad, Mohammadreza Salehi, Abbas Tafakhori, Mohammad Reza Shahmohammadi, et al. (+13) Fereshteh Ghiasvand, Sirous Jafari, Sara Abolghasemi, Farzad Mokhtari, Somayyeh Mahmoodi Baram, Tayebe Zarei, Davood Kazemi, Esmaeil Mohammadnejad, Akram Shah-Hosseini, Alireza Haghbin Toutounchi, So�h Fallah, Ali Riazi, Saeed Karima |
| 90 |
[GO] |
2022―Feb―14 |
Selenium, selenoprotein P, and oxidative stress levels in SARS-CoV-2 patients during illness and recovery |
A. Skesters, D. Kustovs, A. Lece, E. Moreino, E. Petrosina, K. D. Rainsford |
| 91 |
[GO] |
2022―Jan―31 |
Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19 |
Parisa Feizollahi, Somaieh matin, Seyed Askar Roghani, Shayan Mostafaei, Elham Safarzadeh, Mahdi Taghadosi |
| 92 |
[GO] |
2022―Jan―31 |
The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis |
Chia Siang Chia Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 93 |
[GO] |
2022―Jan―20 |
Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection |
Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, Suresh Sharma, Yogendra S. Padwad, Sanjay Kumar |
| 94 |
[GO] |
2022―Jan―03 |
Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination |
Rupinder Kaur, Shareen Singh, Thakur Gurjeet Singh, Pragati Sood, Jiki Robert |
| 95 |
[GO] |
2021―Dec―20 |
Correction to: The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case-control study |
Mahsa Mohajeri, Ehsan Horriatkhah, Reza Mohajery |
| 96 |
[GO] |
2021―Nov―25 |
NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown? |
Mina T. Kelleni |
| 97 |
[GO] |
2021―Oct―28 |
The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a case-control study |
Mahsa Mohajeri, Ehsan Horriatkhah, Reza Mohajery |
| 98 |
[GO] |
2021―Aug―09 |
Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review |
Ekta Singh, Gurubasavaraja Swamy Purawarga Matada, Nahid Abbas, Prasad Sanjay Dhiwar, Abhishek Ghara, Arka Das |
| 99 |
[GO] |
2021―Jul―31 |
Recent updates on immunological, pharmacological, and alternative approaches to combat COVID-19 |
Ammara Saleem, Muhammad Furqan Akhtar, Muhammad Haris, Mohamed M. Abdel-Daim |
| 100 |
[GO] |
2021―Jul―19 |
COVID-19 vaccines and decreased transmission of SARS-CoV-2 |
A. Vitiello, F. Ferrara, V. Troiano, R. La Porta |
| 101 |
[GO] |
2021―Jul―09 |
SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism |
Ali Sepehrinezhad, Ali Gorji, Sajad Sahab Negah |
| 102 |
[GO] |
2021―Jul―05 |
Boswellic acids/Boswellia serrata extract as a potential COVID-19 therapeutic agent in the elderly |
Adel A. Gomaa, Hamdy S. Mohamed, Rasha Bakheet Abd-ellatief, Mohamed A. Gomaa |
| 103 |
[GO] |
2021―Jun―29 |
Shedding light on vitamin D: the shared mechanistic and pathophysiological role between hypovitaminosis D and COVID-19 risk factors and complications |
Esraa Menshawey, Rahma Menshawey, Omnia Azmy Nabeh |
| 104 |
[GO] |
2021―Jun―10 |
Role of vitamins and minerals as immunity boosters in COVID-19 |
Puneet Kumar, Mandeep Kumar, Onkar Bedi, Manisha Gupta, Sachin Kumar, Gagandeep Jaiswal, et al. (+5) Vikrant Rahi, Narhari Gangaram Yedke, Anjali Bijalwan, Shubham Sharma, Sumit Jamwal |
| 105 |
[GO] |
2021―May―03 |
Brief review of the mRNA vaccines COVID-19 |
Antonio Vitiello, Francesco Ferrara |
| 106 |
[GO] |
2021―Apr―21 |
The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis |
Chia Siang Kow, Syed Shahzad Hasan |
| 107 |
[GO] |
2021―Apr―06 |
Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection |
Menizibeya O. Welcome, Nikos E. Mastorakis |
| 108 |
[GO] |
2021―Mar―15 |
Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting |
Sreedhar Amere Subbarao |
| 109 |
[GO] |
2021―Feb―20 |
Correction to: COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties |
Muhammad Asif, Mohammad Saleem, Malik Saadullah, Hafiza Sidra Yaseen, Raghdaa Al Zarzour |
| 110 |
[GO] |
2020―Nov―16 |
COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials |
Desley Butters, Michael Whitehouse |
| 111 |
[GO] |
2020―Nov―07 |
The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients |
Apurva Hariharan, Abdul Rahman Hakeem, Subathra Radhakrishnan, Mettu Srinivas Reddy, Mohamed Rela |
| 112 |
[GO] |
2020―Sep―12 |
ACEIs, ARBs, ibuprofen originally linked to COVID-19: the other side of the mirror |
Mina T. Kelleni |
| 113 |
[GO] |
2020―Aug―14 |
A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality |
Lucinda Smart, Neil Fawkes, Paul Goggin, Graham Pennick, K. D. Rainsford, Bruce Charlesworth, Neil Shah |
| 114 |
[GO] |
2020―Aug―14 |
COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties |
Muhammad Asif, Mohammad Saleem, Malik Saadullah, Hafiza Sidra Yaseen, Raghdaa Al Zarzour |
| 115 |
[GO] |
2020―Jul―07 |
A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms |
Kevin Roe |
